Medicamen Organics 31st AGM: all four resolutions passed with full approval

Board & Shareholder Meetings View source PDF Explain this filing

MEDIORG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹24.15

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%-3.4% vs market

On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-5.0-1.6-3.4

Next day

-0.4-0.6+0.2

—-0.8—

+1.7-2.1+3.8

—-2.1—

—-0.8—

—-3.8—

15d

+5.4-6.9+12.3

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Medicamen Organics held its 31st AGM on September 25, 2026 via video conferencing, from 11:00 AM to 11:35 AM. All four ordinary resolutions passed with 100 percent votes in favour. Items approved: adoption of audited financial statements for FY ended March 31, 2026, re-appointment of Mr. Ashutosh Gupta as director, re-appointment of secretarial auditors for FY27, and material related party transactions with subsidiary Grande Etoile Pharmaceuticals. About 60 percent of outstanding shares were polled.

Likely market impact

Routine AGM outcome. All resolutions approved unanimously. No material change expected for shareholders.